| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 530.00 |
| Borrower/Recipient | 462.50 |
Transforming Egypt's Healthcare System Project
Abstract*
The objective of the Transforming Egypt's Healthcare System Project is to: (i) improve the quality of primary and secondary health care services, (ii) enhance demand for health and family planning services, and (iii) support the prevention and control of Hepatitis C. There are four components to the project, the first component being strengthen primary healthcare, family planning and community activities. This component will mainly finance results... Show More
Development Objective
The proposed Project Development Objective is to (i) improve the quality of primary and secondary health care services, (ii) enhance demand for health and family planning services, (iii) support the prevention and control of Hepatitis C, and (iv) to provide immediate and effective response to an eligible crisis or emergency.
Key Details
Project Details
P167000
Active
Avril Kaplan , Ayodeji Ajiboye
Ministry of Investment and International Cooperation
April 1, 2018
(as of board presentation)
June 27, 2018
September 7, 2018
US$ 992.50 million
Ministry of Health and Population
2018
US$ 530.00 million
B
April 22, 2024
December 31, 2025
Yes
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 530.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 530.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 992.50 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Oct 1, 2019 | IBRD-88950 | Int Charges | 446,578.84 |
| Oct 1, 2019 | IBRD-88950 | Int Charges | 2,990,996.50 |
| Oct 1, 2019 | IBRD-88950 | Int Charges | 28.91 |
| Mar 11, 2020 | IBRD-88950 | Loan Disb | 200,000.00 |
| Mar 12, 2020 | IBRD-88950 | Loan Disb | 36,882,164.00 |
| Apr 1, 2020 | IBRD-88950 | Int Charges | 208,149.38 |
| Apr 1, 2020 | IBRD-88950 | Int Charges | 363,602.30 |
| Apr 1, 2020 | IBRD-88950 | Int Charges | 3,650,775.00 |
| Apr 1, 2020 | IBRD-88950 | Int Charges | 15,124.70 |
| Apr 1, 2019 | IBRD-88950 | Int Charges | 83,284.41 |
| Apr 1, 2019 | IBRD-88950 | Int Charges | 3,074.00 |
| Apr 1, 2019 | IBRD-88950 | Int Charges | 529,963.25 |
| Apr 1, 2019 | IBRD-88950 | Int Charges | 1,902,814.80 |
| Apr 16, 2019 | IBRD-88950 | Loan Disb | 43,410,868.00 |
| Sep 4, 2019 | IBRD-88950 | Loan Disb | 55,406,968.00 |
| Aug 12, 2019 | IBRD-88950 | Loan Disb | 14,244,338.00 |
| Oct 1, 2021 | IBRD-88950 | Loan Disb | 400,000.00 |
| Jun 10, 2022 | IBRD-88950 | Loan Disb | 8,400,000.00 |
| May 31, 2023 | IBRD-88950 | Loan Disb | 4,800,000.00 |
| Mar 7, 2023 | IBRD-88950 | Loan Disb | 1,500,000.00 |
| Apr 1, 2023 | IBRD-88950 | Int Charges | 264,989.56 |
| Apr 1, 2023 | IBRD-88950 | Int Charges | 413,428.30 |
| Apr 1, 2023 | IBRD-88950 | Int Charges | 8,076,099.00 |
| Oct 1, 2022 | IBRD-88950 | Int Charges | 270,759.53 |
| Oct 1, 2022 | IBRD-88950 | Int Charges | 4,384,458.00 |
| Apr 1, 2024 | IBRD-88950 | Int Charges | 168,904.28 |
| Apr 1, 2024 | IBRD-88950 | Int Charges | 258,157.16 |
| Apr 1, 2024 | IBRD-88950 | Int Charges | 11,000,074.00 |
| Apr 1, 2024 | IBRD-88950 | Loan Repay | 5,406,764.00 |
| Jul 29, 2024 | IBRD-88950 | Loan Disb | 11,800,000.00 |
| Oct 1, 2023 | IBRD-88950 | Int Charges | 189,626.44 |
| Oct 1, 2023 | IBRD-88950 | Int Charges | 260,590.39 |
| Oct 1, 2023 | IBRD-88950 | Int Charges | 10,159,267.00 |
| Jun 27, 2018 | IBRD-88950 | Loan Commitment | 530,000,000.00 |
| Oct 1, 2023 | IBRD-88950 | Loan Repay | 5,406,764.00 |
| Oct 1, 2023 | IBRD-88950 | Int Charges | 251.13 |
| Jun 7, 2023 | IBRD-88950 | Loan Disb | 238,414.00 |
| Sep 7, 2018 | IBRD-88950 | Loan Disb | 1,325,000.00 |
| Sep 7, 2018 | IBRD-88950 | Fee Charges | 1,325,000.00 |
| Oct 26, 2018 | IBRD-88950 | Loan Disb | 120,000,000.00 |
| Mar 14, 2019 | IBRD-88950 | Loan Disb | 234,513.00 |
| Apr 11, 2019 | IBRD-88950 | Loan Disb | 247,787.00 |
| Dec 13, 2019 | IBRD-88950 | Loan Disb | 1,000,000.00 |
| Apr 27, 2020 | IBRD-88950 | Loan Disb | 398,508.00 |
| Apr 10, 2020 | IBRD-88950 | Loan Disb | 7,909,000.00 |
| Jun 24, 2020 | IBRD-88950 | Loan Disb | 1,000,000.00 |
| Oct 1, 2019 | IBRD-88950 | Int Charges | 392.04 |
| Oct 1, 2021 | IBRD-88950 | Int Charges | 297.16 |
| Oct 1, 2021 | IBRD-88950 | Int Charges | 1,233.39 |
| Oct 1, 2021 | IBRD-88950 | Int Charges | 288,372.10 |
| Oct 1, 2021 | IBRD-88950 | Int Charges | 1,890,575.50 |
| Apr 23, 2021 | IBRD-88950 | Loan Disb | 10,540,000.00 |
| Jun 21, 2021 | IBRD-88950 | Loan Disb | 12,640,000.00 |
| Apr 1, 2021 | IBRD-88950 | Int Charges | 308,103.94 |
| Apr 1, 2021 | IBRD-88950 | Int Charges | 1,812,260.50 |
| Mar 16, 2021 | IBRD-88950 | Loan Disb | 255,364.00 |
| Mar 9, 2021 | IBRD-88950 | Loan Disb | 600,000.00 |
| Feb 9, 2021 | IBRD-88950 | Loan Disb | 500,000.00 |
| Oct 1, 2020 | IBRD-88950 | Int Charges | 5,067.24 |
| Oct 1, 2020 | IBRD-88950 | Int Charges | 57,783.38 |
| Oct 1, 2020 | IBRD-88950 | Int Charges | 310,806.84 |
| Oct 1, 2020 | IBRD-88950 | Int Charges | 2,974,855.20 |
| Oct 1, 2022 | IBRD-88950 | Int Charges | 513.70 |
| Oct 1, 2022 | IBRD-88950 | Int Charges | 1,965.46 |
| Feb 10, 2022 | IBRD-88950 | Loan Disb | 1,500,000.00 |
| Apr 1, 2022 | IBRD-88950 | Int Charges | 277,230.12 |
| Apr 1, 2022 | IBRD-88950 | Int Charges | 1,848,116.20 |
| May 4, 2022 | IBRD-88950 | Loan Disb | 125,414.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Project Management | Moderately Satisfactory | 2025-03-04 |
| Monitoring and Evaluation | Satisfactory | 2025-03-04 |
| Progress towards achievement of PDO | Moderately Satisfactory | 2025-03-04 |
| Financial Management | Moderately Satisfactory | 2025-03-04 |
| Procurement | Moderately Satisfactory | 2025-03-04 |
| Overall Implementation Progress (IP) | Moderately Unsatisfactory | 2025-03-04 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of PHCs passing Quality Services Index composite indicators list Value 0.00 501.00 600.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Number of people screened for Viral Hepatitis C Value 0.00 49931654.00 35000000.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Contraceptive prevalence rate Value 58.00 66.40 65.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Percentage improvement in the average quality of clinical care score at all targeted hospitals measured through independent direct observations Value 0.00 86.40 80.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Number of clinical screenings of suspected COVID-19 cases by a trained physician/nurse at port of entries, quarantine facilities, community and/or healthcare facilities Value 0.00 200000.00 200000.00 Date January 28, 2021 March 31, 2024 December 31, 2025 Comment Percentage improvement in the average quality of clinical care score at all targeted PHCs, measured through independent direct observations Value 0.00 80.00 80.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Percentage of blood units dispensed at MOHP affiliated hospitals that have been screened utilizing the Nucleic Acid test Value 0.00 0.00 90.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Percent Female Value 0.00 52.00 50.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Percentage of people who received treatment for Hepatitis C who have taken the final confirmation test for sustained virological response (SVR) using a random sampling methodology Value 0.00 75.00 80.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
PHC mapping exercise, needs assessments and new accreditation tool completed. Value 0.00 4.00 4.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Project results published regularly on external MOHP website Value 0 Yes Yes Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Targeted regional blood banks that have been connected to the national automated blood network. Value 0.00 0.00 11.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Increased household visits by CHWs Value 7.00 36.00 32.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Targeted Hep C patients treated Value 0.00 1179356.00 1500000.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Percentage of participating districts certified for enhanced governance performance Value 0.00 100.00 100.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Percent Female Value 0.00 45.00 40.00 Date June 20, 2018 March 31, 2024 December 31, 2025 Comment Client user satisfaction and utilization surveys conducted in project target areas Value 0.00 4.00 5.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Number of PHCs receiving National Accreditation Certification for healthcare quality Value 0.00 0.00 600.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Grievances addressed in project target facilities using the GRM in accordance with the revised manual issued in 2017 Value 0.00 94.00 80.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Number of Hospitals receiving National Accreditation Certification for healthcare quality in target governorates Value 0.00 0.00 27.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Average patient satisfaction level Value 0.00 88.70 65.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Number of plasma centers passing the PQI composite indicator. Value 0.00 0.00 10.00 Date January 28, 2021 March 31, 2024 December 31, 2025 Comment Targeted people screened for NCDs Value 0.00 49931654.00 20000000.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Number of plasma units that were properly collected, transferred, tested and stored. Value 0.00 0.00 250000.00 Date January 28, 2021 March 31, 2024 December 31, 2025 Comment Number of conducted rounds of the national online licensing/specialization examinations. Value 0.00 0.00 2.00 Date January 28, 2021 March 31, 2024 December 31, 2025 Comment Percent Female Value 0.00 52.00 50.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Targeted PHCs applying environmentally-positive energy and water efficiency measures Value 0.00 501.00 600.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment People who have received essential health, nutrition, and population (HNP) services Value 0.00 2185129.00 3400000.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment Number of women and children who have received basic nutrition services Value 0.00 2185129.00 3400000.00 Date July 2, 2018 March 31, 2024 December 31, 2025 Comment